Novavax Inc

NVAXNASDAQ · USD
10.11USD0.00 (+1.10%)
269

Novavax Inc (NVAX) Implied Volatility Current

NVAX implied volatility is 70%. IV Rank is 17%, placing current premiums in the bottom of their 52-week range.

Read more

Tracking NVAX implied volatility helps you identify when options premiums on Novavax Inc are historically cheap or expensive, and where the best trades are hiding. Novavax Inc implied volatility reflects the market's expectation of future price movement: when NVAX IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Novavax Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For NVAX, tracking metrics like NVAX IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on NVAX signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics.

It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where NVAX implied volatility sits today versus where it has been. Our scanner ranks Novavax Inc implied volatility against its historical range, surfaces extremes in NVAX IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Novavax Inc IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
16.67%IV Rank
Low

IV is compressed vs the past year - options are relatively cheap, favoring buyers.

Implied Volatility (30d)69.73%

IV Rank16.67%

Historical Volatility (30d)58.05%

IV - HV+11.68%

As of September 18, 2026

Trade options with IV on your side

Track NVAX IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial